TESTING UPDATE – March 19, 2020

At this time, testing for COVID-19 is only helpful for patients experiencing symptoms of fever, cough, and/or shortness of breath. Even for people at risk for developing more severe illness or people with known COVID-19 contacts, testing is not recommended or ordered before the onset of symptoms. People without symptoms should stay home and monitor themselves for fever, cough or shortness of breath. Individuals who are experiencing fever, cough, or shortness of breath, please call the practice.

Coronavirus COVID-19 Global Cases, Courtesy of  “Johns Hopkins University” , 


From CDC:

Remdesivir for treatment of hospitalized patients with COVID-19 and pneumonia

There are currently four options for obtaining remdesivir for treatment of hospitalized patients with COVID-19 and pneumonia in the United States:”

A National Institutes of Health (NIH)-sponsored adaptive double-blinded, placebo-controlled trial of remdesivir versus placebo in COVID-19 patients with pneumonia and hypoxia is enrolling non-pregnant persons aged 18 years and older with oxygen saturation of ≤94% on room air or requiring supplemental oxygen or mechanical ventilation (https://clinicaltrials.gov/ct2/show/NCT04280705external icon).

Receiving outside a clincial trial:

“…Finally, in areas without clinical trials, COVID-19 patients in the United States and other countries have been treated with remdesivir on an uncontrolled compassionate use basis. The manufacturer is currently transitioning the provision of emergency access to remdesivir from individual compassionate use requests to an expanded access program.  The expanded access program for the United States is under rapid development. Further information is available at: https://rdvcu.gilead.com/external icon…”

Information for Clinicians on Therapeutic Options for COVID-19 Patients